Cardiovascular

Association of the geriatric nutritional risk index with mortality in patients with rheumatoid arthritis: A cohort study from the NHANES 2007-2018.

TL;DR

A lower geriatric nutritional risk index (GNRI) was associated with higher all-cause mortality among participants with rheumatoid arthritis, with those having GNRI <98 showing 84% higher risk compared to those with GNRI ≥98.

Key Findings

Patients with rheumatoid arthritis had a significantly lower GNRI than those without RA.

  • Mean GNRI was 102.7 in RA participants versus 105.1 in non-RA participants.
  • The difference was statistically significant (P < .001).
  • Data were drawn from NHANES 2007–2018.
  • GNRI was evaluated both continuously (per 1-unit increase) and categorically (< 98 vs ≥ 98).

Patients with rheumatoid arthritis had higher all-cause and cardiovascular mortality rates than those without RA.

  • All-cause mortality was 10.0% in RA participants versus 6.6% in non-RA participants.
  • Cardiovascular mortality was 2.7% in RA participants versus 1.5% in non-RA participants.
  • These comparisons were made using NHANES 2007–2018 data with follow-up through death or end of study period.

Higher GNRI was associated with a lower risk of all-cause mortality in patients with rheumatoid arthritis in the fully adjusted model.

  • Hazard ratio per 1-unit increase in GNRI was 0.94 (95% CI, 0.89–1.00; P = .032).
  • This association was found using survey-weighted Cox proportional hazards models.
  • The model was fully adjusted for relevant covariates.

RA participants with a GNRI < 98 had a significantly higher risk of all-cause mortality compared to those with GNRI ≥ 98.

  • Hazard ratio for all-cause mortality with GNRI < 98 versus ≥ 98 was 1.84 (95% CI, 1.12–3.04; P = .017).
  • The cutoff of 98 was used as the categorical threshold for nutritional risk classification.
  • This analysis was conducted in the fully adjusted Cox proportional hazards model.

Neither continuous nor categorical GNRI was significantly associated with cardiovascular mortality in patients with rheumatoid arthritis.

  • P > .05 for both continuous and categorical GNRI analyses for cardiovascular mortality.
  • Competing-risk analyses were conducted as secondary analyses.
  • Restricted cubic spline, subgroup, and sensitivity analyses were also performed as secondary analyses.

What This Means

This research examined whether a simple nutritional scoring tool called the Geriatric Nutritional Risk Index (GNRI) — which uses a person's weight, height, and blood albumin levels — could predict the risk of death in people with rheumatoid arthritis (RA). Using data from a large U.S. national survey (NHANES) collected between 2007 and 2018, the researchers found that people with RA already had lower nutritional scores on average than people without RA, and also had higher rates of death from any cause and from heart disease during the follow-up period. The study found that among people with RA, those with a lower GNRI score (specifically below 98, indicating nutritional risk) were 84% more likely to die from any cause during the study period compared to those with higher scores. Each one-unit increase in the GNRI score was associated with a 6% reduction in all-cause mortality risk. However, the GNRI score was not significantly linked to deaths specifically caused by cardiovascular disease. This research suggests that poor nutritional status, as measured by the GNRI, may identify people with rheumatoid arthritis who are at greater risk of dying. Since the GNRI is inexpensive and easy to calculate in clinical settings, it could potentially be used to flag high-risk patients for closer monitoring or nutritional intervention. However, the authors caution that further prospective studies are needed to determine whether GNRI adds meaningful predictive value beyond other established risk factors in RA management.

Have a question about this study?

Citation

Wen Z, Wang S, Li Y, Tu X, Zhang Q, Qing Y. (2026). Association of the geriatric nutritional risk index with mortality in patients with rheumatoid arthritis: A cohort study from the NHANES 2007-2018.. Medicine. https://doi.org/10.1097/MD.0000000000050312